CD44 and cancer: Since HNSCC is revealed as the second highest CD44-expressing tumor in the Pan-Cancer Atlas [5], we examined the reactivity of C44Mab-18 and C44Mab-46 in immunohistochemical analyses using FFPE sections of OSCC tissue array.